secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corteva, Inc. (CTVA)
CIK:        0001755672
Form:       8-K
Filed at:   2022-11-03T23:59:59+00:00
Accession:  0001755672-22-000022
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Corteva reports Q3 GAAP loss $322M; raises full-year EBITDA mid-point; to acquire Symborg
--------------------------------------------------------------------------------

- Q3 net sales $2.78B (+17% YoY); GAAP EPS $(0.45); operating EBITDA $96M vs ($51M) prior year.
- YTD net sales $13.63B (+12%); GAAP EPS $1.72; operating EBITDA $2.85B (+23%).
- Crop Protection Q3 operating EBITDA $352M (+71%) on pricing and new product penetration.
- Raised full-year operating EBITDA guidance to $3.0-3.1B; net sales guidance affirmed $17.2-17.5B.
- Signed agreement to acquire biologicals leader Symborg; exiting commodity glyphosate ($300M 2023 headwind).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1755672/000175567222000022/0001755672-22-000022-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1755672/000175567222000022/ctva-20221103.htm
  HTML page:      https://secwatch.observer/filing/0001755672-22-000022

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer